Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The comp... Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. Mehr anzeigen
Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...
Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates PR Newswire SAN DIEGO, Nov. 7, 2024 Completed enrollment in the fourth cohort of the Phase 1b...
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant...
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences PR Newswire SAN DIEGO, Aug. 28, 2024 SAN DIEGO, Aug. 28, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 5.09554140127 | 1.57 | 1.77 | 1.52 | 318402 | 1.64845194 | CS |
| 4 | 0.26 | 18.7050359712 | 1.39 | 1.77 | 1.3 | 260411 | 1.56654751 | CS |
| 12 | 0 | 0 | 1.65 | 1.8 | 1.3 | 337398 | 1.54282519 | CS |
| 26 | -0.77 | -31.8181818182 | 2.42 | 2.59 | 1.3 | 510546 | 1.81170606 | CS |
| 52 | 0.3 | 22.2222222222 | 1.35 | 3.78 | 1.08 | 1095067 | 2.23250131 | CS |
| 156 | 1.3014 | 373.321858864 | 0.3486 | 3.78 | 0.1576 | 755085 | 1.40346749 | CS |
| 260 | 0.97 | 142.647058824 | 0.68 | 3.78 | 0.1576 | 1232364 | 1.20830679 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
